The future of biomanufacturing: is Belgium ready?

Wednesday, November 25, 2020
12:30 to 14:30



Member price


AmCham Belgium is pleased to invite you to the third event of the Year of Healthcare!

Belgium is considered to be one of the world’s most prominent research nations. Our Belgian ecosystem is highly valued internationally thanks to its excellent performance across the entire biotech value chain. Also at the level of biological medicines, Belgium plays a key role. Novel therapies like cell therapy, gene therapy, plasma products, and monoclonal antibodies are being discovered at the most rapid pace. However, new discoveries also require new biomanufacturing processes.

As the new Federal Government announced that it wants to make Belgium a true biotech valley, is the country ready for the future of biomanufacturing? Does Belgium hold the pole position in creating the factory of the future? What are Belgium's assets? Are companies able to find and develop the talent they need to grow?

Join us for an interactive online event on November 25 and hear first-hand what experts consider the challenges, opportunities and future trends of biomanufacturing in Belgium. The platform will also give you the opportunity to take part in speed networking with industry peers and other key stakeholders.


12:30 – Networking

1:00 p.m. – Introduction by the Innovative Healthcare Committee of AmCham Belgium

1:05 p.m. - Keynote speech by Lieven Comeyne (Partner within the Life Sciences Supply Chain & Operations team at Deloitte + member of the Life Sciences EMEA leadership team) 

1:15 p.m. - Panel discussion with Q&A with Geoffrey Pot (VP Operations - External Supply & Innovation at Takeda), Veerle Van der Linden (General Manager at ViTalent), Julien Moindrot (Site Head Sanofi Geel), Moderation: Tineke Van hooland (Deputy Secretary-General of

1:55 p.m. - Concluding remarks by Tineke Van hooland (Deputy Secretary-General of

2:00 p.m. - Networking

2:30 p.m. - End

YoH Partners